6/16/16 - Trevena to Present at the JMP Life Sciences Conference
6/8/16 - Trevena, Inc. Announces First Patients Enrolled in the APOLLO-1 and APOLLO-2 Phase 3 Pivotal Efficacy Studies of Oliceridine in Acute Pain
6/1/16 - Trevena to Present at the Jefferies 2016 Healthcare Conference
We have identified three product candidates as potential best-in-class or first-in-class therapies for patients suffering from serious unmet medical needs.